Cargando…

The first titin (c.59926 + 1G > A) founder mutation associated with dilated cardiomyopathy

Detalles Bibliográficos
Autores principales:	Hoorntje, Edgar T., van Spaendonck‐Zwarts, Karin Y., te Rijdt, Wouter P., Boven, Ludolf, Vink, Aryan, van der Smagt, Jasper J., Asselbergs, Folkert W., van Wijngaarden, Jan, Hennekam, Eric A., Pinto, Yigal M., Lekanne Deprez, Ronald H., Barge‐Schaapveld, Daniela Q.C.M., Bootsma, Marianne, Regieli, Jakub, Hoedemaekers, Yvonne M., Jongbloed, Jan D.H., van den Berg, Maarten P., van Tintelen, J. Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2017
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993291/ https://www.ncbi.nlm.nih.gov/pubmed/29057560 http://dx.doi.org/10.1002/ejhf.1030

Ejemplares similares

Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated Cardiomyopathy
por: Akinrinade, Oyediran, et al.
Publicado: (2019)

Publisher Correction: Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated Cardiomyopathy
por: Akinrinade, Oyediran, et al.
Publicado: (2020)

Titin Circular RNAs Create a Back-Splice Motif Essential for SRSF10 Splicing
por: Tijsen, Anke J., et al.
Publicado: (2021)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants
por: Jansen, Mark, et al.
Publicado: (2023)

A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects
por: van der Linde, I. H. M., et al.
Publicado: (2017)

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
por: Marsili, Luisa, et al.
Publicado: (2023)

Genetic advances in sarcomeric cardiomyopathies: state of the art
por: Ho, Carolyn Y., et al.
Publicado: (2015)

BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status
por: Jansen, M., et al.
Publicado: (2021)

Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy
por: van den Wijngaard, A., et al.
Publicado: (2011)

Titin and diaphragm dysfunction in mechanically ventilated rats
por: van Hees, Hieronymus W. H., et al.
Publicado: (2012)

Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D
por: van Spaendonck-Zwarts, K. Y., et al.
Publicado: (2012)

Heritability in genetic heart disease: the role of genetic background
por: Jansweijer, Joeri A, et al.
Publicado: (2019)

The arrhythmogenic cardiomyopathy phenotype associated with PKP2 c.1211dup variant
por: Bos, Thomas A., et al.
Publicado: (2023)

KBTBD13 is a novel cardiomyopathy gene
por: de Winter, Josine M., et al.
Publicado: (2022)

The Frank–Starling Law: a jigsaw of titin proportions
por: Sequeira, Vasco, et al.
Publicado: (2017)

Familial occurrence of mitral regurgitation in patients with mitral valve prolapse undergoing mitral valve surgery
por: Hiemstra, Yasmine L, et al.
Publicado: (2019)

Titin‐based mechanosensing modulates muscle hypertrophy
por: van der Pijl, Robbert, et al.
Publicado: (2018)

PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies
por: van Paassen, Barbara W, et al.
Publicado: (2014)

Terminal osseous dysplasia with pigmentary defects and cardiomyopathy caused by a novel FLNA variant
por: Rumping, Lynne, et al.
Publicado: (2021)

Prenatal diagnosis of a trisomy 7/trisomy 13 mosaicism
por: Huijsdens-van Amsterdam, Karin, et al.
Publicado: (2012)

Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk Stratification
por: van der Meulen, Marijke H., et al.
Publicado: (2022)

Flight of the titins
por: Dove, Alan W.
Publicado: (2001)

Clash of the titin
por: LeBrasseur, Nicole
Publicado: (2002)

Titin–N2A: More than a signaling node?
por: van der Pijl, Robbert J., et al.
Publicado: (2021)

Downsizing the molecular spring of the giant protein titin reveals that skeletal muscle titin determines passive stiffness and drives longitudinal hypertrophy
por: Brynnel, Ambjorn, et al.
Publicado: (2018)

Lack of evidence for a causal role of CALR3 in monogenic cardiomyopathy
por: Verhagen, Judith M. A., et al.
Publicado: (2018)

Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance
por: van Spaendonck-Zwarts, Karin Y., et al.
Publicado: (2011)

Peripartum cardiomyopathy: Euro Observational Research Program
por: Hoes, M. F., et al.
Publicado: (2014)

P62‐positive aggregates are homogenously distributed in the myocardium and associated with the type of mutation in genetic cardiomyopathy
por: van der Klooster, Zoë Joy, et al.
Publicado: (2021)

A titinic extension
por: Wells, William A.
Publicado: (2002)

Of cilia, titin, and neurosteroids
por: Adler, Elizabeth M.
Publicado: (2014)

Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant
por: Hoorntje, Edgar T., et al.
Publicado: (2022)

End‐diastolic force pre‐activates cardiomyocytes and determines contractile force: role of titin and calcium
por: Najafi, Aref, et al.
Publicado: (2019)

A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial
por: van den Heuvel, Lieke M, et al.
Publicado: (2019)

Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)
por: Murray, Brittney, et al.
Publicado: (2018)

International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
por: James, Cynthia A., et al.
Publicado: (2021)

No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy
por: Hoorntje, Edgar T., et al.
Publicado: (2018)

Case series, chemotherapy-induced cardiomyopathy: mind the family history!
por: Moghadasi, Setareh, et al.
Publicado: (2021)

A new spring for titin
por: Brunello, Elisabetta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_remtg8cbmjck2n8i15c579sj3g